Mural Oncology Plc Stock Alpha and Beta Analysis
| MURA Stock | 3.44 0.20 5.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mural Oncology plc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mural Oncology over a specified time horizon. Remember, high Mural Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Mural Oncology's market risk premium analysis include:
Beta 0.91 | Alpha 0.0375 | Risk 3.21 | Sharpe Ratio 0.0138 | Expected Return 0.0442 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Mural |
Mural Oncology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mural Oncology market risk premium is the additional return an investor will receive from holding Mural Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mural Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mural Oncology's performance over market.| α | 0.04 | β | 0.91 |
Mural Oncology expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Mural Oncology's Buy-and-hold return. Our buy-and-hold chart shows how Mural Oncology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Mural Oncology Market Price Analysis
Market price analysis indicators help investors to evaluate how Mural Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mural Oncology shares will generate the highest return on investment. By understating and applying Mural Oncology stock market price indicators, traders can identify Mural Oncology position entry and exit signals to maximize returns.
Mural Oncology Return and Market Media
The median price of Mural Oncology for the period between Wed, Sep 18, 2024 and Tue, Dec 17, 2024 is 3.46 with a coefficient of variation of 7.72. The daily time series for the period is distributed with a sample standard deviation of 0.27, arithmetic mean of 3.52, and mean deviation of 0.21. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Insider Trading | 09/20/2024 |
2 | Armistice Capital LLC Takes Position in Mural Oncology plc - MarketBeat | 09/27/2024 |
3 | Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 10/02/2024 |
4 | Mural Oncology to Present Clinical and Preclinical Data at the th Annual Meeting of the Society for Immunotherapy of Cancer | 10/07/2024 |
5 | Disposition of 7421 shares by Cutler Adam D. of Mural Oncology at 3.41 subject to Rule 16b-3 | 10/31/2024 |
6 | Disposition of 5069 shares by Goodman Vicki L of Mural Oncology at 3.33 subject to Rule 16b-3 | 11/07/2024 |
7 | Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress | 11/13/2024 |
8 | Rodman Renshaw Initiates Coverage of Mural Oncology with Buy Recommendation - MSN | 11/22/2024 |
9 | Analysts Give Strong Buy Rating To This Undervalued Medical Stock With Up To 350 percent Of Share Price Upside | 12/02/2024 |
About Mural Oncology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mural or other stocks. Alpha measures the amount that position in Mural Oncology plc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Mural Oncology Upcoming Company Events
As portrayed in its financial statements, the presentation of Mural Oncology's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mural Oncology's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Mural Oncology's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Mural Oncology. Please utilize our Beneish M Score to check the likelihood of Mural Oncology's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Mural Oncology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Mural Oncology Backtesting, Mural Oncology Valuation, Mural Oncology Correlation, Mural Oncology Hype Analysis, Mural Oncology Volatility, Mural Oncology History and analyze Mural Oncology Performance. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Mural Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.